Management of cancer of the base of tongue.
The management of base of tongue cancer has evolved steadily over time. Organ preservation with primary radiation therapy has produced excellent oncologic and functional outcomes. Concomitant chemotherapy has become important in patients with locoregionally advanced disease. Planned neck dissection after organ preservation therapy continues to be an integral step for regional control. This article reports the results of a literature review of base of tongue cancer emphasizing a multidisciplinary approach to obtain optimal results in terms of cure and quality of life.
Han
Peter
P
Continuum Cancer Centers of New York, Beth Israel Medical Center, St. Luke's Roosevelt Hospital, New York Eye & Ear Infirmary, New York, NY, USA. phan@bethisrael.org
Hu
Kenneth
K
Frank
Douglas K
DK
Sessions
Roy B
RB
Harrison
Louis B
LB
D000970:Antineoplastic Agents / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D005927:Glossectomy; D006801:Humans; D009367:Neoplasm Staging; D011788:Quality of Life; D018714:Radiotherapy, Adjuvant; D014062:Tongue Neoplasms / Q000473:pathology* / Q000628:therapy*; D016896:Treatment Outcome
D000970:Antineoplastic Agents